Carl L Gordon sold $5.7M of Compass Therapeutics (CMPX)

Executed Apr 9 2025, disclosed Apr 11 2025, 2 days later.

Value, as filed

$5.7M

3,571,428 sh × $1.59

Executed

Apr 9 2025

the trade date, as filed

Disclosed

Apr 11 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CG Carl L Gordon Director profile →

Carl L Gordon (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in BlossomHill Therapeutics, Inc. Common Stock (BLSM). Across 2 priced purchase filings, the average 21-session return was +56.2% from execution and +52.9% from disclosure (delay-adjusted; derived). The largest single filing was $15.0M of SCTX (1,000,000 sh × $15.00, as filed), executed Jul 27.

The name

CMPX CMPX CMPX · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→